시장보고서
상품코드
1303139

이미징 CRO 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측(2017-2027년)

Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2017-2027 Segmented By Services Offered, By Imaging Modality, By Clinical Trial Phase, By Application, By End User, By company & By Region

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 119 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 이미징 CRO 시장은 2023년부터 2027년까지 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다.

주요 요인으로는 임상시험의 증가, R&D 비용의 지속적인 증가, 기술의 광범위한 발전 등이 시장 성장을 촉진하는 주요 요인입니다. 의료 이미징은 새로운 생명과학 제품의 임상적 진보에 효과적인 역할을 하고 있습니다. 생명공학 및 제약 산업의 확장, 다양한 질병을 치료하는 신약 개발을 위한 R&D 투자 증가는 시장 산업의 성장을 촉진할 것으로 보입니다. 그 외 시장 성장을 뒷받침하는 요인으로는 연구개발 활동 증가, 연구개발 비용 증가, 이미징 프로세스의 자동화, 이미징 기술 활용 확대 및 컴퓨팅 능력 향상, 합병 및 전략적 인수합병 증가 등이 있습니다.

의료영상 연간 임상시험 건수 증가가 시장 성장을 뒷받침

임상 연구의 증가로 인한 임상시험의 증가가 시장 성장을 견인하고 있습니다. 이미징 CRO는 중요한 영역에 대한 많은 정보와 인사이트를 제공함으로써 연구자들을 돕고 있습니다. 또한 의료기기, 생명공학, 제약 등 다양한 산업에 품질, 비용 효율성 및 제조 능력을 추가하고 있습니다. 임상시험에서 의료 영상의 중요성이 높아지면서 시장 성장에 박차를 가하고 있습니다. 2018년 Keosys Medical Imaging의 기사에 따르면, 매년 실시되는 임상시험의 총 수는 2010년에 비해 2020년에 거의 두 배로 증가할 것으로 예상했습니다.

시장 성장을 촉진하는 R&D 활동 및 지출 증가

연구개발(R&D) 활동이 활발해지면서 시장 성장을 견인하고 있습니다. 방사선 및 영상 과학 분야의 연구 증가는 중요한 기술을 창출하고 인간의 이상과 질병을 식별하고 치료하기 위해 장비를 사용하는 최신 기술을 연마하는 데 도움이 되고 있습니다. 현재 의료영상의 도움을 받아 의료, 수술 및 행동학적 개입을 평가하기 위해 다양한 임상 연구가 진행되고 있습니다. 또한 연구 개발 비용의 지속적인 증가는 시장 성장을 촉진하고 있습니다.

이미징 CRO 프로세스에서 자동화 도입 증가

최근 몇 년 동안 기술의 급속한 발전은 시장 성장을 촉진하고 있습니다. 이미징 CRO 프로세스 자동화와 같은 발전은 생명공학 및 제약 산업에 큰 영향을 미치고 있습니다. 이미징 CRO 프로세스의 자동화는 프로세스를 효과적이고 효율적으로 만듭니다. 따라서 이미징 프로세스에서 자동화 채택이 증가하고 있으며, 이는 시장 성장을 촉진하고 있습니다. 예를 들어, 2021년 Abbott는 자사의 새로운 Ultreon 소프트웨어로 운영되는 최신 광학 일관성 단층촬영(OCT) 이미징 플랫폼이 FDA 승인을 받았다고 발표했습니다. 이 첨단 이미징 소프트웨어는 OCT와 인공지능을 결합하여 의사에게 관상동맥 혈류와 막힘에 대한 향상된 종합적인 뷰를 제공하여 의사의 의사 결정을 돕고 치료를위한 최상의 경로를 제공합니다.

사용 가능한 커스터마이징

TechSci Research는 주어진 시장 데이터를 사용하여 기업의 특정 요구에 따라 맞춤화할 수 있습니다. 보고서에서 다음과 같은 커스터마이징이 가능합니다.

회사 소개

  • 추가 시장 진입 기업(최대 5개사)에 대한 심층 분석 및 프로파일링

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 이미징 CRO 시장에 미치는 영향

제5장 고객의 소리

제6장 세계의 이미징 CRO 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제공 서비스별
    • 이미징 모달리티별
    • 임상시험 단계별
    • 용도별
    • 최종사용자별
    • 지역별
    • 기업별
  • 시장 맵

제7장 북미의 이미징 CRO 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제공 서비스별
    • 이미징 모달리티별
    • 임상시험 단계별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제8장 유럽의 이미징 CRO 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제공 서비스별
    • 이미징 모달리티별
    • 임상시험 단계별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 아시아태평양의 이미징 CRO 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제공 서비스별
    • 이미징 모달리티별
    • 임상시험 단계별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제10장 남미의 이미징 CRO 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제공 서비스별
    • 이미징 모달리티별
    • 임상시험 단계별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 이미징 CRO 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제공 서비스별
    • 이미징 모달리티별
    • 임상시험 단계별
    • 용도별
    • 최종사용자별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 터키
    • 이집트

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

제14장 경쟁 상황

  • Laboratory Corporation of America Holdings
  • IXICO PLC
  • ICON plc
  • The Micron Group
  • Medpace Holdings, Inc.
  • Radiant Sage LLC
  • Biomedical Systems Corporation
  • Worldcare Clinical, LLC
  • Imaging Endpoints LLC
  • Parexel International Corporation

제15장 전략적 제안

ksm 23.08.21

The global imaging clinical research organization (CRO) market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the growing number of clinical trials, continuous growth in R&D spending, and extensive advancement in technology are impelling the growth of the market. Medical imaging plays an effective role in the clinical advancement of novel life science products. The expansion of the biotechnology and pharmaceutical industries, along with increased research and development investments for developing new drugs to treat various diseases, is likely to drive the market industry growth. The other factors supporting the market's growth are, rise in R&D activities, increasing R&D expenditure, a rise in automation of imaging process, increasing usage of imaging technology and the enhanced power of computing, and a growing number of mergers and strategic acquisitions.

An increase in the Annual Number of Clinical Trials with Medical Imaging supports Market Growth.

A growing number of clinical trials due to the rise in clinical research is augmenting the growth of the market. Imaging Clinical Research Organizations help researchers by providing massive amounts of information and insights into key areas. They are adding quality, cost-effectiveness, and manufacturing capacity to various industries such as medical devices, biotechnology, and pharmaceutical. The growing significance of medical imaging in clinical trials is fueling the growth of the market. According to a Keosys Medical Imaging article, in 2018, the total number of clinical trials performed each year almost doubled in 2020 compared to 2010.

Growth in R&D Activities and spending to foster the Market Growth

The rise in research and development (R&D) activities is bolstering the growth of the market. Rising research in the field of radiology and imaging sciences are helping to generate critical technologies, as well as honed modern techniques for using equipment to identify and treat abnormalities and disease in humans. Nowadays, various clinical studies are done to evaluate medical, surgical, and behavioral interventions with the help of medical imaging. Also, continuous growth in R&D spending is facilitating the growth of the market.

Increasing Adoption of Automation in Imaging CRO Process

Over the past few years, rapid advancements in technology are propelling the growth of the market. Advancements such as automation in the Imaging CRO process are making a huge impact on the biotechnology and pharmaceutical industries. Automation in the imaging CRO process makes the process effective and efficient; also, it helps to control errors and minimize time. Thus, the increasing adoption of automation in the imaging process encourages the growth of the market. For instance, in 2021, Abbott announced that it had received FDA clearance for the latest optical coherence tomography (OCT) imaging platform operated by the company's new Ultreon Software. This advanced imaging software combines OCT with artificial intelligence to offer physicians an enhanced, comprehensive view of coronary blood flow and blockages to aid physician decision-making and offer the best route for treatment.

Market Segmentation

The global imaging clinical research organization (CRO) market is segmented into services offered, imaging modality, clinical trial phase, application, end user, and company. Based on the services offered, the market is divided into imaging acquisition and protocol development, application design, image collection, and quality control, digital image conversion, support and maintenance, and others. Based on imaging modality, the market is divided into computed tomography (CT) scans, magnetic resonance imaging (MRI), positron emission tomography (PET), and others. Based on the clinical trial phase, the market is divided into Phase 1, phase 2, and Phase 3. Based on application, the market is divided into oncology, neurology, cardiovascular, ophthalmology, and others. Based on end-user, the market is divided into pharmaceutical & biotechnology companies, medical device manufacturers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of clinical studies in the country.

Market Players

Laboratory Corporation of America Holdings, IXICO PLC, ICON plc, The Micron Group, Medpace Holdings, Inc., Radiant Sage LLC, Biomedical Systems Corporation, Worldcare Clinical, LLC, Imaging Endpoints LLC, and Parexel International Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global imaging clinical research organization (CRO) market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Imaging Clinical Research Organization (CRO) Market, By Services Offered:

  • Imaging Acquisition and Protocol Development
  • Application Design
  • Image Collection and Quality Control
  • Digital Image Conversion
  • Support and Maintenance
  • Others

Imaging Clinical Research Organization (CRO) Market, By Imaging Modality:

  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Others

Imaging Clinical Research Organization (CRO) Market, By Clinical Trial Phase:

  • Phase 1
  • Phase 2
  • Phase 3

Imaging Clinical Research Organization (CRO) Market, By application:

  • Oncology
  • Neurology
  • Cardiovascular
  • Ophthalmology
  • Others

Imaging Clinical Research Organization (CRO) Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic & Research Institutions
  • Others

Imaging Clinical Research Organization (CRO) Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Imaging Clinical Research Organization (CRO) Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Imaging Clinical Research Organization (CRO) Market

5. Voice of Customer

6. Global Imaging Clinical Research Organization (CRO) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Services Offered (Imaging Acquisition and Protocol Development, Application Design, Image Collection and Quality Control, Digital Image Conversion, Support and Maintenance, Others)
    • 6.2.2. By Imaging Modality (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Others)
    • 6.2.3. By Clinical Trial Phase (Phase 1, Phase 2, Phase 3)
    • 6.2.4. By Application (Oncology, Neurology, Cardiovascular, Ophthalmology, Others)
    • 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Imaging Clinical Research Organization (CRO) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Services Offered
    • 7.2.2. By Imaging Modality
    • 7.2.3. By Clinical Trial Phase
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Services Offered
        • 7.3.1.2.2. By Imaging Modality
        • 7.3.1.2.3. By Clinical Trial Phase
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Services Offered
        • 7.3.2.2.2. By Imaging Modality
        • 7.3.2.2.3. By Clinical Trial Phase
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Services Offered
        • 7.3.3.2.2. By Imaging Modality
        • 7.3.3.2.3. By Clinical Trial Phase
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Imaging Clinical Research Organization (CRO) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Services Offered
    • 8.2.2. By Imaging Modality
    • 8.2.3. By Clinical Trial Phase
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Services Offered
        • 8.3.1.2.2. By Imaging Modality
        • 8.3.1.2.3. By Clinical Trial Phase
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Services Offered
        • 8.3.2.2.2. By Imaging Modality
        • 8.3.2.2.3. By Clinical Trial Phase
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Services Offered
        • 8.3.3.2.2. By Imaging Modality
        • 8.3.3.2.3. By Clinical Trial Phase
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Services Offered
        • 8.3.4.2.2. By Imaging Modality
        • 8.3.4.2.3. By Clinical Trial Phase
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Services Offered
        • 8.3.5.2.2. By Imaging Modality
        • 8.3.5.2.3. By Clinical Trial Phase
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Imaging Clinical Research Organization (CRO) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Services Offered
    • 9.2.2. By Imaging Modality
    • 9.2.3. By Clinical Trial Phase
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Services Offered
        • 9.3.1.2.2. By Imaging Modality
        • 9.3.1.2.3. By Clinical Trial Phase
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Services Offered
        • 9.3.2.2.2. By Imaging Modality
        • 9.3.2.2.3. By Clinical Trial Phase
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Services Offered
        • 9.3.3.2.2. By Imaging Modality
        • 9.3.3.2.3. By Clinical Trial Phase
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Services Offered
        • 9.3.4.2.2. By Imaging Modality
        • 9.3.4.2.3. By Clinical Trial Phase
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Services Offered
        • 9.3.5.2.2. By Imaging Modality
        • 9.3.5.2.3. By Clinical Trial Phase
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Imaging Clinical Research Organization (CRO) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Services Offered
    • 10.2.2. By Imaging Modality
    • 10.2.3. By Clinical Trial Phase
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Services Offered
        • 10.3.1.2.2. By Imaging Modality
        • 10.3.1.2.3. By Clinical Trial Phase
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Services Offered
        • 10.3.2.2.2. By Imaging Modality
        • 10.3.2.2.3. By Clinical Trial Phase
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Services Offered
        • 10.3.3.2.2. By Imaging Modality
        • 10.3.3.2.3. By Clinical Trial Phase
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Imaging Clinical Research Organization (CRO) Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Services Offered
    • 11.2.2. By Imaging Modality
    • 11.2.3. By Clinical Trial Phase
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Services Offered
        • 11.3.1.2.2. By Imaging Modality
        • 11.3.1.2.3. By Clinical Trial Phase
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Services Offered
        • 11.3.2.2.2. By Imaging Modality
        • 11.3.2.2.3. By Clinical Trial Phase
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Services Offered
        • 11.3.3.2.2. By Imaging Modality
        • 11.3.3.2.3. By Clinical Trial Phase
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Services Offered
        • 11.3.4.2.2. By Imaging Modality
        • 11.3.4.2.3. By Clinical Trial Phase
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Services Offered
        • 11.3.5.2.2. By Imaging Modality
        • 11.3.5.2.3. By Clinical Trial Phase
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Laboratory Corporation of America Holdings
  • 14.2. IXICO PLC
  • 14.3. ICON plc
  • 14.4. The Micron Group
  • 14.5. Medpace Holdings, Inc.
  • 14.6. Radiant Sage LLC
  • 14.7. Biomedical Systems Corporation
  • 14.8. Worldcare Clinical, LLC
  • 14.9. Imaging Endpoints LLC
  • 14.10. Parexel International Corporation

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제